Our guest today is Mati Gill, CEO of AION Labs. AION Labs has an innovative company creation process that empowers startups to tackle high-impact challenges with AI, backed by top-tier data, funding, and expertise.
Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space.
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]